Study Underscores Cost Advantages of Telemedicine for Common Conditions

According to a recent LinkedIn post from Vori Health, new research from Penn Medicine suggests that telemedicine visits may be substantially less expensive than traditional in-office care for many common conditions. The post notes that the study, published in JAMA Network Open, compared costs and utilization patterns between virtual and in-person encounters.

The company’s LinkedIn post highlights that telemedicine episodes were reported to cost about $96 on average versus $509 for in-person care, implying roughly a fivefold difference in episode costs. It also notes that patients starting with telemedicine reportedly had fewer follow-up visits than those whose care began in person.

As shared in the post, the findings appeared particularly favorable for conditions such as respiratory symptoms, where cost and follow-up reductions were more pronounced. In contrast, the post indicates that cost differences between visit types were narrower for mental and behavioral health services.

For investors, the post suggests that evidence of telemedicine’s potential cost efficiency and lower follow-up utilization could support long-term demand for virtual-first care models. If such cost advantages are validated at scale, companies positioned in telehealth and hybrid care, such as Vori Health, may benefit from payor interest in value-based arrangements and broader adoption by cost-conscious healthcare systems.

The research emphasis on specific conditions may also influence how telemedicine providers prioritize service lines and product design. A stronger economic case in areas like respiratory care, coupled with more moderate differences in behavioral health, could guide resource allocation and partnership strategies as the sector continues to mature.